2024
DOI: 10.1021/acsomega.3c09794
|View full text |Cite
|
Sign up to set email alerts
|

Ultrasonic or Microwave Modified Continuous Flow Chemistry for the Synthesis of Tetrahydrocannabinol: Observing Effects of Various Solvents and Acids

Giovanni A. Ramirez,
Tesfay T. Tesfatsion,
Maite L. Docampo-Palacios
et al.

Abstract: Synthesizing tetrahydrocannabinol is a lengthy process with minimal yields and little applicability on an industrial scale. To close the gap between bench chemistry and industry process chemistry, this paper introduces a small-scale flow chemistry method that utilizes a microwave or ultrasonic medium to produce major tetrahydrocannabinol isomers. This process produces excellent yields and minimal side products, which leads to more efficient large-scale production of the desired cannabinoids.

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

1
0

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 36 publications
0
1
0
Order By: Relevance
“…Tetrahydrocannabinol (THC), the primary psychoactive component of Cannabis sativa, is accompanied in most consumer-ready products by a slew of minor cannabinoids, most notably CBD, which is nonpsychoactive. In recent years, the synthetic production of THC variants, such as Δ 8 -THC and Δ 9 -THC, has become a focal point within the hemp industry, presenting both opportunities and challenges. While the potential therapeutic benefits of cannabinoids are widely acknowledged, a recent surge in popularity and availability of these products raises concerns about their quality, safety, and legality.…”
Section: Introductionmentioning
confidence: 99%
“…Tetrahydrocannabinol (THC), the primary psychoactive component of Cannabis sativa, is accompanied in most consumer-ready products by a slew of minor cannabinoids, most notably CBD, which is nonpsychoactive. In recent years, the synthetic production of THC variants, such as Δ 8 -THC and Δ 9 -THC, has become a focal point within the hemp industry, presenting both opportunities and challenges. While the potential therapeutic benefits of cannabinoids are widely acknowledged, a recent surge in popularity and availability of these products raises concerns about their quality, safety, and legality.…”
Section: Introductionmentioning
confidence: 99%